WYA Europe takes a stand in the EU debate on Advanced Therapy Medicinal Products

Advanced therapies: advancing human dignity?

On January 30th, the European Parliament Committee for Environment and Public Health (ENVI) approved a report on: “The proposal for a regulation of the European Parliament and of the Council on advanced therapy medicinal products”.  Amendments to the report and the final report itself are now due to be voted on by Members of the European Parliament (MEPs) during a Plenary session of the Parliament in Strasbourg. The WYA worked with members of the ENVI committee prior to their approval of the Report at the end of January. The aim of the proposed Regulation is to create a single European authorisation process for the placing of advanced therapy medicinal products on the market under the single market provisions of the European Treaties. This Regulation will cover new forms of treatment, including gene therapy, cell therapy and tissue engineering. Any types of products that are excluded from this regulation will be less attractive for research and development. By upholding fundamental ethical principles and calling for the exclusion of certain types of products from the scope of the Regulation, we can make our contribution to ensure that the Regulation will not be used in a way which undermines human dignity and fundamental values. Click here to read more.